BioMarin Pharmaceutical
BMRN
#1968
Rank
HK$81.90 B
Marketcap
HK$423.76
Share price
-0.02%
Change (1 day)
-6.68%
Change (1 year)

P/S ratio for BioMarin Pharmaceutical (BMRN)

P/S ratio as of May 2026 (TTM): 3.20

According to BioMarin Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.71. At the end of 2026 the company had a P/S ratio of 3.21.

P/S ratio history for BioMarin Pharmaceutical from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.21-9.43%
20253.55-20.63%
20244.47-40.5%
20237.51-18.18%
20229.184.45%
20218.792.68%
20208.56-4.11%
20198.92-12.33%
201810.2-14.62%
201711.9-6.55%
201612.8-32.91%
201519.05.92%
201418.0-2.43%
201318.448.85%
201212.438.95%
20118.9012.36%
20107.9235.37%
20095.85-2.4%
20085.99-78.8%
200728.358.38%
200617.9-42.79%
200531.241.13%
200422.1-16.81%
200326.6-2.43%
200227.2-60.02%
200168.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Sanofi
SNY
1.91-40.26%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
3.46 8.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
2.15-32.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
2.65-17.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.17 123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
6.50 102.98%๐Ÿ‡บ๐Ÿ‡ธ USA